PRO-ADM FOR THERAPY MONITORING OF INTENSIVE CARE UNIT PATIENTS Application EP-4027145-A1 European Patent Office 13 Jul 2022
PROADRENOMEDULLIN AS A MARKER FOR ABNORMAL PLATELET LEVELS Application EP-3971573-A1 European Patent Office 23 Mar 2022
PROADRENOMEDULLIN AS A MARKER FOR ABNORMAL PLATELET LEVELS Application EP-3971572-A1 European Patent Office 23 Mar 2022
PROADRENOMEDULLIN AS A MARKER FOR ABNORMAL PLATELET LEVELS Application WO-2019053118-A1 World Intellectual Property Organisation (WIPO) 21 Mar 2019